Form D · Biotechnology
Novan, Inc.
Durham, NC · CIK 0001467154
Offering snapshot reported Dec 30, 2015 · SEC filing
- Reported sold
- $32.8M Offering amount: $32.8M
- Investors reported
- 172 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 1, 2015 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$30,409,735 → $32,840,304
- Reported investors146 → 172
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 30, 2015 | Amendment | $32,840,304 | $2,430,569vs Dec 16, 2015 | 172 | SEC filing |
| Dec 16, 2015 | Initial | $30,409,735 | No comparison | 146 | SEC filing |
| Mar 30, 2015 | Amendment | $50,000,008 | $39,674,915vs Aug 29, 2014 | 91 | SEC filing |
| Aug 29, 2014 | Initial | $10,325,093 | No comparison | 61 | SEC filing |
| Mar 10, 2014 | Initial | $3,502,125 | No comparison | 36 | SEC filing |
| Feb 28, 2013 | Amendment | $11,000,000 | $5,830,000vs May 31, 2012 | 50 | SEC filing |
| May 31, 2012 | Initial | $5,170,000 | No comparison | 17 | SEC filing |
| Sep 29, 2011 | Amendment | $5,999,968 | $2,949,974vs Nov 18, 2010 | 12 | SEC filing |
| Aug 29, 2011 | Amendment | $5,599,986 | $2,549,992vs Nov 18, 2010 | 11 | SEC filing |
| Jan 18, 2011 | Amendment | $3,999,992 | $949,998vs Nov 18, 2010 | 9 | SEC filing |
| Nov 18, 2010 | Initial | $3,049,994 | No comparison | 9 | SEC filing |
| Jul 2, 2009 | Initial | $2,000,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-253231
Source: Form D, filed Dec 30, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| W Kent Geer | Director |
| W. Kent Geer | Director |
| F. Neal Hunter | Director |
| F Neal Hunter | Director |
| Robert A Ingram | Director |
| G Kelly Martin | Director |
| G. Kelly Martin | Director |
| Sean Murphy | Director |
| John W Palmour | Director |
| Richard Peterson | Executive |
| Robert P Ruscher | Director |
| Mark Schoenfisch | Director |
| Nathan Stasko | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4222 Emperor Blvd Suite 200
Durham, NC, 27703
Durham, NC, 27703